• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21188.0
  • ISIN : INE361B01024
7,386.50 57 (0.77%)
  • As on 23 Jul 2026 (EOD)
  • Today’s Low

    7,219.50
  • Today’s High

    7,398.00
  • Open

    7,330.00
  • Perv Close

    7,330.00
  • 52W Low

    5,636.50
  • 52W High

    7,438.50

Key Indicators

  • P/E(TTM)

    73.65

  • Mar.Cap (₹Cr.)

    196,088.37

  • Div & Yield %

    0.41

  • Book Value(₹)

    629.49

  • Debt-Equity Ratio

    0.77

  • AGM Date

    22-Jul-2026

  • EPS

    100.29

  • P/E Ratio

    73.65

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    196,088.37

  • RONW (%)

    12.15

  • ROCE (%)

    16.41

Score Board

  • Equity (₹ in Cr.)

    53.09

  • BV (₹)

    629.50

  • Sales( ₹ in Cr.)

    10,388.00

  • NP (in Cr.)

    2,662.28

  • NP Var(%)

    21.0

  • Div%

    1500.0

  • CPS (₹)

    117.70

  • EPS (₹)

    100.30

  • Traded Value (₹ in Lakhs)

    196,095.00

  • 52 Week High

    7,438.50

  • 52 Week Low

    5,636.50

  • Price BSE

    7387.0

  • Price NSE

    7,387.00

  • Market Capital( in Cr.)

    196,095.00

  • P/C Ratio

    62.80

  • P/E Ratio

    73.70

  • Price Vs.BV

    100.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 10,388.00 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10,388.00 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61
Other Income 506.00 352.00 337.00 349.00 111.26 62.53
Stock Adjustments 244.00 83.00 127.00 -50.00 449.99 100.00
Total Income 11,138.00 9,633.00 8,129.00 7,924.00 9,441.07 6,961.14
EXPENDITURE :            
Raw Materials 4,339.00 3,827.00 3,270.00 3,035.00 3,499.18 2,416.47
Power and Fuel Cost 530.00 465.00 477.00 496.00 390.05 319.15
Employee Cost 1,400.00 1,210.00 1,067.00 953.00 926.55 808.68
Other Manufacturing Expenses 325.00 276.00 299.00 285.00 255.38 202.29
Selling and Administration Expenses 509.00 460.00 367.00 402.00 340.16 292.53
Miscellaneous Expenses 114.00 63.00 137.00 55.00 40.95 37.69
Employee Benefit Expenses 1,400.00 1,210.00 1,067.00 953.00 926.55 808.68
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,217.00 6,301.00 5,617.00 5,226.00 5,452.27 4,076.81
Operating Profit 3,921.00 3,332.00 2,512.00 2,698.00 3,988.80 2,884.33
Interest 24.00 2.00 4.00 2.00 1.73 1.81
Gross Profit 3,897.00 3,330.00 2,508.00 2,696.00 3,987.07 2,882.52
Depreciation 461.00 401.00 376.00 342.00 310.55 254.65
Profit Before Tax 3,436.00 2,929.00 2,132.00 2,354.00 3,676.52 2,627.87
Current Tax 869.00 793.00 511.00 438.00 637.20 609.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -40.00 -73.00 45.00 108.00 90.78 64.10
Reported Net Profit 2,607.00 2,209.00 1,576.00 1,808.00 2,948.54 1,954.72
Extraordinary Items -55.28 0.00 0.74 3.07 -1.65 -2.45
Adjusted Net Profit 2,662.28 2,209.00 1,575.26 1,804.93 2,950.19 1,957.17
Adjustment below Net Profit 6.00 -2.00 -1.00 2.00 2.18 0.16
P & L Balance brought forward 13,357.00 11,725.00 10,922.00 9,967.00 7,588.31 5,814.44
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 604.00 575.00 772.00 855.00 571.50 181.01
P & L Balance carried down 15,366.00 13,357.00 11,725.00 10,922.00 9,967.53 7,588.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,500.00 1,500.00 1,500.00 1,500.00 1,500.00 1,000.00
Dividend Per Share(Rs) 30.00 30.00 30.00 30.00 30.00 20.00
Earnings Per Share-Unit Curr 98.38 83.36 59.47 68.23 111.08 73.64
Earnings Per Share(Adj)-Unit Curr 98.38 83.36 59.47 68.23 111.08 73.64
Book Value 630.60 562.08 508.83 479.43 440.44 349.28
Book Value(Adj)-Unit Curr 630.60 562.08 508.83 479.43 440.44 349.28

Shareholding Pattern

  • Promoter Group

    51.88%

  • Public Share Holding

    48.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000,000 3.01 8,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 129,735,090 48.87 129,735,090 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 137,735,090 51.88 137,735,090 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 3,602 0.00 3,602 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 210,955 0.08 210,955 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 53,865,707 20.29 53,865,707 746
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 12,579,940 4.74 12,579,940 24
Mutual Funds / UTI 35,636,887 13.42 35,636,887 43
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,594,258 0.98 2,594,258 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 104,891,349 39.51 104,891,349 842
2] Non Institution
Bodies Corporate 3,146,844 1.19 3,146,844 1,356
Clearing Members 3,951 0.00 3,951 7
Directors of their Relatives 739,505 0.28 739,505 12
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,185,154 0.45 1,185,154 8,920
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 283,683 0.11 283,683 3,015
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,286,500 0.48 1,286,500 7
Individuals holding nominal share capital up to Rs. 1 lakh 15,902,950 5.99 15,833,559 213,795
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 263,509 0.10 263,509 44
Others 30,045 0.01 30,045 2
Sub Total 22,842,141 8.60 22,772,750 227,158
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 265,468,580 100.00 265,399,189 228,006

Company Background

Divis Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Divis Laboratories Ltd
  • BSE Code : 21188.0
  • ISIN : INE361B01024
  • Incorporation Year

    1990

  • Registered Office

    1-72-23(P)/DIVIS/303 Divi Towe
    Cyber Hills Gachibowli, Hyderabad,
    Telangana-500032

  • Telephone

    91-40-23786300/23786352/400

  • FAX

    91-40-23786460

  • Chairman

    Ramesh B V Nimmagadda

  • Managing Director

    Murali K Divi

  • Company Secretary

    Satish Choudhury

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Divis Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Divi's Lab. 7,386.75 10,894.00 10,388.00 75.22 21.38
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77